Cardio Diagnostics (CDIO) Announces 1:30 Reverse Share Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- US stock futures tumble as Trump says Iran deal is 'over', oil climbs
- Oil jumps over 4% to two-week high after Trump says deal with Iran 'over'
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Amazon launches bond sale seeking at least $25 billion
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
May 8, 2025 8:35 AM EDTCHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Cardio or the Company) (NASDAQ: CDIO), today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.
The reverse stock split will take effect at 11:59 pm Eastern Time on May 12, 2025, and the Companys common stock will open for trading on The Nasdaq Capital Market on May 13, 2025 on a post-split basis, under the existing ticker symbol CDIO but with new CUSIP number 14159C202. The reverse stock split is part of the Companys plan to regain compliance with the minimum bid... More
